Unknown

Dataset Information

0

Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.


ABSTRACT: The secreted glycoprotein sclerostin has recently emerged as a key negative regulator of Wnt signaling in bone and has stimulated considerable interest as a potential target for therapeutics designed to treat conditions associated with low bone mass, such as osteoporosis. We have determined the structure of sclerostin, which resulted in the identification of a previously unknown binding site for heparin, suggestive of a functional role in localizing sclerostin to the surface of target cells. We have also mapped the interaction site for an antibody that blocks the inhibition of Wnt signaling by sclerostin. This shows minimal overlap with the heparin binding site and highlights a key role for this region of sclerostin in protein interactions associated with the inhibition of Wnt signaling. The conserved N- and C-terminal arms of sclerostin were found to be unstructured, highly flexible, and unaffected by heparin binding, which suggests a role in stabilizing interactions with target proteins.

SUBMITTER: Veverka V 

PROVIDER: S-EPMC2667775 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Veverka Vaclav V   Henry Alistair J AJ   Slocombe Patrick M PM   Ventom Andrew A   Mulloy Barbara B   Muskett Frederick W FW   Muzylak Mariusz M   Greenslade Kevin K   Moore Adrian A   Zhang Li L   Gong Jianhua J   Qian Xueming X   Paszty Chris C   Taylor Richard J RJ   Robinson Martyn K MK   Carr Mark D MD  

The Journal of biological chemistry 20090210 16


The secreted glycoprotein sclerostin has recently emerged as a key negative regulator of Wnt signaling in bone and has stimulated considerable interest as a potential target for therapeutics designed to treat conditions associated with low bone mass, such as osteoporosis. We have determined the structure of sclerostin, which resulted in the identification of a previously unknown binding site for heparin, suggestive of a functional role in localizing sclerostin to the surface of target cells. We  ...[more]

Similar Datasets

| S-EPMC4052706 | biostudies-literature
| S-EPMC2212719 | biostudies-literature
| S-EPMC4501925 | biostudies-literature
| S-EPMC291840 | biostudies-literature
| S-EPMC5014086 | biostudies-literature
| S-EPMC2694443 | biostudies-literature
| S-EPMC3009889 | biostudies-literature
| S-EPMC3639248 | biostudies-literature
| S-EPMC8032393 | biostudies-literature
| S-EPMC4616053 | biostudies-other